Methylphenidate Hydrochloride Tablet, Extended Release — FDA Drug Shortage
The FDA lists a drug shortage record for Methylphenidate Hydrochloride Tablet, Extended Release (tablet) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Jul 26, 2023. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 62037-726-01
- Dosage Form
- Tablet
- Presentation
- Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)
- Initial Posting
- Jul 26, 2023
Reason
Other